PLSI - Phoenix Life Sciences International Limited

Other OTC - Other OTC Delayed Price. Currency in USD

Phoenix Life Sciences International Limited

3000 Lawrence Street
Denver, CO 80205
United States

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Martin TindallFounder, CEO & DirectorN/AN/AN/A
Mr. Geoff BoyntonCFO, Company Sec. & DirectorN/AN/AN/A
Mr. Stephen CornfordAdvisor, Director of Investment & Audit and DirectorN/AN/AN/A
Ms. Janelle MarsdenMD & DirectorN/AN/AN/A
Mr. John M. TaleoGlobal Head of SecurityN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. It focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancer, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. The company offers transdermal patches, medi-strips, capsules, vaporizing pharmaceutical grade cannabis, and medi-mist oral sprays, as well as soft gel capsules, thin film dissolvable strips, sublingual oral sprays, suppositories, and topical creams. It is also involved in the distribution of medical cannabis-based products. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. The company was incorporated in 2009 and is headquartered in Denver, Colorado.

Corporate Governance

Phoenix Life Sciences International Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.